Sickle cell treatments: $3 for Vitamin D, $3 Million for gene cell
A $3 Million Cure — If It Works: Medicaid’s Gene Therapy Gamble Meets a Cheaper Challenger If Approved
"As reported by KFF Health News, the Centers for Medicare & Medicaid Services (CMMS) has negotiated outcomes-based contracts for two FDA-approved therapies from Vertex Pharmaceuticals and Bluebird Bio, priced at $2.2 million and $3.1 million per patient, excluding long hospital stays. If outcomes fall short—typically defined as freedom from severe pain crises—manufacturers owe rebates."
Sickle cell continues to be treated by Vitamin D, but there is no profit in using it
- Vitamin D should be an almost universal feature of the care of young adults with sickle cell disease
- Sickle Cell treated by Vitamin D - many studies
- 14000 IU vitamin D (50000 twice a week) often stops Sickle Cell pain
- Vitamin D deficiency exacerbates many Sickle Cell problems - Perplexity AI,
- African American Health Disparities are associated with low Vitamin D - Grant
- Gut-Friendly Vitamin D 10+ types, low cost
- Prebiotics increased Vitamin D in celiac disease patients (gut-friendly Vit. D also helps) – RCT
Prevalence of Vitamin D deficiency in patients with sickle cell disease - 2013
